See the DrugPatentWatch profile for Fenofibrate
Fenofibrate 48 mg tablets are a lower-dose formulation of the medication fenofibrate, used to lower cholesterol and triglycerides in the blood. This dose is typically prescribed for patients who require a less potent therapeutic effect or as a starting dose for titration.
What is Fenofibrate and How Does it Work?
Fenofibrate belongs to a class of drugs called fibrates. It works by affecting fat metabolism in the body. Specifically, it can decrease elevated levels of triglycerides and cholesterol (LDL) while increasing levels of HDL cholesterol, often referred to as "good cholesterol." By modulating these lipid levels, fenofibrate aims to reduce the risk of cardiovascular events such as heart attacks and strokes [1].
What are the Different Strengths of Fenofibrate Available?
Fenofibrate is available in various strengths, including 48 mg, 50 mg, 145 mg, and 160 mg tablets. The specific dosage prescribed depends on the individual patient's lipid profile and medical history [2]. The 48 mg tablet represents one of the lower available doses.
When Might a Doctor Prescribe Fenofibrate 48 mg?
A physician might prescribe the 48 mg fenofibrate tablet for patients who have mild to moderate dyslipidemia, which is an abnormal amount of lipids (fats) in the blood. It could also be used as an initial treatment before increasing the dose if needed. It is often prescribed for individuals with mixed hyperlipidemia, characterized by high levels of both triglycerides and cholesterol, or for those with hypertriglyceridemia, where triglyceride levels are significantly elevated [3].
What are the Potential Side Effects of Fenofibrate?
Common side effects associated with fenofibrate use can include gastrointestinal issues like diarrhea, nausea, and abdominal pain. Other potential side effects may involve headache, dizziness, rash, and muscle pain [1][3]. More serious, though less common, side effects can include liver problems, pancreatitis, and muscle damage (myopathy). Patients are advised to report any unusual symptoms to their healthcare provider [3].
How Does Fenofibrate Compare to Other Lipid-Lowering Medications?
Fenofibrate, as a fibrate, primarily targets triglyceride reduction and modestly affects LDL and HDL cholesterol. Other classes of lipid-lowering drugs, such as statins, are generally considered the first-line treatment for lowering LDL cholesterol. Statins are often more effective at reducing LDL and have well-established cardiovascular benefits. Fenofibrate may be used in combination with a statin or as an alternative for patients who cannot tolerate statins or for whom statins alone are insufficient, particularly those with very high triglyceride levels [4].
What is the Patent Status for Fenofibrate?
The original patents for fenofibrate have long expired, allowing for the availability of generic versions of the drug. This means that different pharmaceutical companies can manufacture and market their own versions of fenofibrate, including the 48 mg tablet. DrugPatentWatch.com tracks patent information for medications, and for older drugs like fenofibrate, the primary patent protection has lapsed [5].
Who Manufactures Generic Fenofibrate 48 mg Tablets?
As the patent for the original fenofibrate has expired, numerous generic pharmaceutical manufacturers produce fenofibrate 48 mg tablets. These include companies like Teva Pharmaceuticals, Aurobindo Pharma, and Accord Healthcare, among others. The availability and specific manufacturer can vary by region and pharmacy [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugs.com/fenofibrate.html
3. https://www.nhs.uk/medicines/fenofibrate/
4. https://www.heart.org/en/health-topics/cholesterol/about-cholesterol/statins-and-other-cholesterol-lowering-medicines
5. https://www.drugpatentwatch.com/drug/fenofibrate